0001628280-23-006533.txt : 20230306
0001628280-23-006533.hdr.sgml : 20230306
20230306162953
ACCESSION NUMBER: 0001628280-23-006533
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230302
FILED AS OF DATE: 20230306
DATE AS OF CHANGE: 20230306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MILNE GEORGE M JR
CENTRAL INDEX KEY: 0001179552
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36421
FILM NUMBER: 23709298
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aurinia Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001600620
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: #1203-4464 MARKHAM STREET
CITY: VICTORIA BC
STATE: A1
ZIP: V8Z 7X8
BUSINESS PHONE: 250-708-4272
MAIL ADDRESS:
STREET 1: #1203-4464 MARKHAM STREET
CITY: VICTORIA BC
STATE: A1
ZIP: V8Z 7X8
4
1
wf-form4_167813818041525.xml
FORM 4
X0306
4
2023-03-02
0
0001600620
Aurinia Pharmaceuticals Inc.
AUPH
0001179552
MILNE GEORGE M JR
#1203-4464 MARKHAM STREET
VICTORIA
A1
V8Z7X8
BRITISH COLUMBIA, CANADA
1
0
0
0
Common Stock
2023-03-02
4
P
0
20000
8.9142
A
70000
D
The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $8.86 to $8.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
/s/ George M. Milne, Jr., Ph.D.
2023-03-06